Global Malaria Vaccines Market Research Report 2023

Global Malaria Vaccines Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Malaria Vaccines Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Pre-Erythrocytic Vaccine
1.2.3 Erythrocytic Vaccine
1.2.4 Multi-antigen Vaccine
1.3 Market by Application
1.3.1 Global Malaria Vaccines Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Community Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Malaria Vaccines Market Perspective (2018-2029)
2.2 Malaria Vaccines Growth Trends by Region
2.2.1 Global Malaria Vaccines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Malaria Vaccines Historic Market Size by Region (2018-2023)
2.2.3 Malaria Vaccines Forecasted Market Size by Region (2024-2029)
2.3 Malaria Vaccines Market Dynamics
2.3.1 Malaria Vaccines Industry Trends
2.3.2 Malaria Vaccines Market Drivers
2.3.3 Malaria Vaccines Market Challenges
2.3.4 Malaria Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Malaria Vaccines Players by Revenue
3.1.1 Global Top Malaria Vaccines Players by Revenue (2018-2023)
3.1.2 Global Malaria Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Malaria Vaccines Revenue
3.4 Global Malaria Vaccines Market Concentration Ratio
3.4.1 Global Malaria Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Malaria Vaccines Revenue in 2022
3.5 Malaria Vaccines Key Players Head office and Area Served
3.6 Key Players Malaria Vaccines Product Solution and Service
3.7 Date of Enter into Malaria Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Malaria Vaccines Breakdown Data by Type
4.1 Global Malaria Vaccines Historic Market Size by Type (2018-2023)
4.2 Global Malaria Vaccines Forecasted Market Size by Type (2024-2029)
5 Malaria Vaccines Breakdown Data by Application
5.1 Global Malaria Vaccines Historic Market Size by Application (2018-2023)
5.2 Global Malaria Vaccines Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Malaria Vaccines Market Size (2018-2029)
6.2 North America Malaria Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Malaria Vaccines Market Size by Country (2018-2023)
6.4 North America Malaria Vaccines Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Malaria Vaccines Market Size (2018-2029)
7.2 Europe Malaria Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Malaria Vaccines Market Size by Country (2018-2023)
7.4 Europe Malaria Vaccines Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Malaria Vaccines Market Size (2018-2029)
8.2 Asia-Pacific Malaria Vaccines Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Malaria Vaccines Market Size by Region (2018-2023)
8.4 Asia-Pacific Malaria Vaccines Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Malaria Vaccines Market Size (2018-2029)
9.2 Latin America Malaria Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Malaria Vaccines Market Size by Country (2018-2023)
9.4 Latin America Malaria Vaccines Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Malaria Vaccines Market Size (2018-2029)
10.2 Middle East & Africa Malaria Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Malaria Vaccines Market Size by Country (2018-2023)
10.4 Middle East & Africa Malaria Vaccines Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Company Detail
11.1.2 GlaxoSmithKline Plc Business Overview
11.1.3 GlaxoSmithKline Plc Malaria Vaccines Introduction
11.1.4 GlaxoSmithKline Plc Revenue in Malaria Vaccines Business (2018-2023)
11.1.5 GlaxoSmithKline Plc Recent Development
11.2 Sanaria Inc
11.2.1 Sanaria Inc Company Detail
11.2.2 Sanaria Inc Business Overview
11.2.3 Sanaria Inc Malaria Vaccines Introduction
11.2.4 Sanaria Inc Revenue in Malaria Vaccines Business (2018-2023)
11.2.5 Sanaria Inc Recent Development
11.3 Nobelpharma Co
11.3.1 Nobelpharma Co Company Detail
11.3.2 Nobelpharma Co Business Overview
11.3.3 Nobelpharma Co Malaria Vaccines Introduction
11.3.4 Nobelpharma Co Revenue in Malaria Vaccines Business (2018-2023)
11.3.5 Nobelpharma Co Recent Development
11.4 Sumaya Biotech
11.4.1 Sumaya Biotech Company Detail
11.4.2 Sumaya Biotech Business Overview
11.4.3 Sumaya Biotech Malaria Vaccines Introduction
11.4.4 Sumaya Biotech Revenue in Malaria Vaccines Business (2018-2023)
11.4.5 Sumaya Biotech Recent Development
11.5 GenVec
11.5.1 GenVec Company Detail
11.5.2 GenVec Business Overview
11.5.3 GenVec Malaria Vaccines Introduction
11.5.4 GenVec Revenue in Malaria Vaccines Business (2018-2023)
11.5.5 GenVec Recent Development
11.6 Actiza Pharmaceutical Private Limited
11.6.1 Actiza Pharmaceutical Private Limited Company Detail
11.6.2 Actiza Pharmaceutical Private Limited Business Overview
11.6.3 Actiza Pharmaceutical Private Limited Malaria Vaccines Introduction
11.6.4 Actiza Pharmaceutical Private Limited Revenue in Malaria Vaccines Business (2018-2023)
11.6.5 Actiza Pharmaceutical Private Limited Recent Development
11.7 AdvaCare Pharma
11.7.1 AdvaCare Pharma Company Detail
11.7.2 AdvaCare Pharma Business Overview
11.7.3 AdvaCare Pharma Malaria Vaccines Introduction
11.7.4 AdvaCare Pharma Revenue in Malaria Vaccines Business (2018-2023)
11.7.5 AdvaCare Pharma Recent Development
11.8 Ipca Laboratories Ltd
11.8.1 Ipca Laboratories Ltd Company Detail
11.8.2 Ipca Laboratories Ltd Business Overview
11.8.3 Ipca Laboratories Ltd Malaria Vaccines Introduction
11.8.4 Ipca Laboratories Ltd Revenue in Malaria Vaccines Business (2018-2023)
11.8.5 Ipca Laboratories Ltd Recent Development
11.9 Bliss GVS Pharma Ltd
11.9.1 Bliss GVS Pharma Ltd Company Detail
11.9.2 Bliss GVS Pharma Ltd Business Overview
11.9.3 Bliss GVS Pharma Ltd Malaria Vaccines Introduction
11.9.4 Bliss GVS Pharma Ltd Revenue in Malaria Vaccines Business (2018-2023)
11.9.5 Bliss GVS Pharma Ltd Recent Development
11.10 GeoVax
11.10.1 GeoVax Company Detail
11.10.2 GeoVax Business Overview
11.10.3 GeoVax Malaria Vaccines Introduction
11.10.4 GeoVax Revenue in Malaria Vaccines Business (2018-2023)
11.10.5 GeoVax Recent Development
11.11 Pfizer Inc
11.11.1 Pfizer Inc Company Detail
11.11.2 Pfizer Inc Business Overview
11.11.3 Pfizer Inc Malaria Vaccines Introduction
11.11.4 Pfizer Inc Revenue in Malaria Vaccines Business (2018-2023)
11.11.5 Pfizer Inc Recent Development
11.12 VLP Therapeutics
11.12.1 VLP Therapeutics Company Detail
11.12.2 VLP Therapeutics Business Overview
11.12.3 VLP Therapeutics Malaria Vaccines Introduction
11.12.4 VLP Therapeutics Revenue in Malaria Vaccines Business (2018-2023)
11.12.5 VLP Therapeutics Recent Development
11.13 OSIVAX
11.13.1 OSIVAX Company Detail
11.13.2 OSIVAX Business Overview
11.13.3 OSIVAX Malaria Vaccines Introduction
11.13.4 OSIVAX Revenue in Malaria Vaccines Business (2018-2023)
11.13.5 OSIVAX Recent Development
11.14 AJANTA PHARMA
11.14.1 AJANTA PHARMA Company Detail
11.14.2 AJANTA PHARMA Business Overview
11.14.3 AJANTA PHARMA Malaria Vaccines Introduction
11.14.4 AJANTA PHARMA Revenue in Malaria Vaccines Business (2018-2023)
11.14.5 AJANTA PHARMA Recent Development
11.15 Strides Pharma Science Limited
11.15.1 Strides Pharma Science Limited Company Detail
11.15.2 Strides Pharma Science Limited Business Overview
11.15.3 Strides Pharma Science Limited Malaria Vaccines Introduction
11.15.4 Strides Pharma Science Limited Revenue in Malaria Vaccines Business (2018-2023)
11.15.5 Strides Pharma Science Limited Recent Development
11.16 Mylan N.V.
11.16.1 Mylan N.V. Company Detail
11.16.2 Mylan N.V. Business Overview
11.16.3 Mylan N.V. Malaria Vaccines Introduction
11.16.4 Mylan N.V. Revenue in Malaria Vaccines Business (2018-2023)
11.16.5 Mylan N.V. Recent Development
11.17 Zydus Cadila
11.17.1 Zydus Cadila Company Detail
11.17.2 Zydus Cadila Business Overview
11.17.3 Zydus Cadila Malaria Vaccines Introduction
11.17.4 Zydus Cadila Revenue in Malaria Vaccines Business (2018-2023)
11.17.5 Zydus Cadila Recent Development
11.18 Cipla Inc
11.18.1 Cipla Inc Company Detail
11.18.2 Cipla Inc Business Overview
11.18.3 Cipla Inc Malaria Vaccines Introduction
11.18.4 Cipla Inc Revenue in Malaria Vaccines Business (2018-2023)
11.18.5 Cipla Inc Recent Development
11.19 Sun Pharmaceutical Industries Ltd
11.19.1 Sun Pharmaceutical Industries Ltd Company Detail
11.19.2 Sun Pharmaceutical Industries Ltd Business Overview
11.19.3 Sun Pharmaceutical Industries Ltd Malaria Vaccines Introduction
11.19.4 Sun Pharmaceutical Industries Ltd Revenue in Malaria Vaccines Business (2018-2023)
11.19.5 Sun Pharmaceutical Industries Ltd Recent Development
11.20 Sanofi
11.20.1 Sanofi Company Detail
11.20.2 Sanofi Business Overview
11.20.3 Sanofi Malaria Vaccines Introduction
11.20.4 Sanofi Revenue in Malaria Vaccines Business (2018-2023)
11.20.5 Sanofi Recent Development
11.21 Hikma Pharmaceuticals PLC
11.21.1 Hikma Pharmaceuticals PLC Company Detail
11.21.2 Hikma Pharmaceuticals PLC Business Overview
11.21.3 Hikma Pharmaceuticals PLC Malaria Vaccines Introduction
11.21.4 Hikma Pharmaceuticals PLC Revenue in Malaria Vaccines Business (2018-2023)
11.21.5 Hikma Pharmaceuticals PLC Recent Development
11.22 Amneal Pharmaceuticals LLC
11.22.1 Amneal Pharmaceuticals LLC Company Detail
11.22.2 Amneal Pharmaceuticals LLC Business Overview
11.22.3 Amneal Pharmaceuticals LLC Malaria Vaccines Introduction
11.22.4 Amneal Pharmaceuticals LLC Revenue in Malaria Vaccines Business (2018-2023)
11.22.5 Amneal Pharmaceuticals LLC Recent Development
11.23 Taj Pharmaceuticals Limited
11.23.1 Taj Pharmaceuticals Limited Company Detail
11.23.2 Taj Pharmaceuticals Limited Business Overview
11.23.3 Taj Pharmaceuticals Limited Malaria Vaccines Introduction
11.23.4 Taj Pharmaceuticals Limited Revenue in Malaria Vaccines Business (2018-2023)
11.23.5 Taj Pharmaceuticals Limited Recent Development
11.24 Lupin
11.24.1 Lupin Company Detail
11.24.2 Lupin Business Overview
11.24.3 Lupin Malaria Vaccines Introduction
11.24.4 Lupin Revenue in Malaria Vaccines Business (2018-2023)
11.24.5 Lupin Recent Development
11.25 Novartis AG
11.25.1 Novartis AG Company Detail
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Malaria Vaccines Introduction
11.25.4 Novartis AG Revenue in Malaria Vaccines Business (2018-2023)
11.25.5 Novartis AG Recent Development
11.26 CellFree Sciences
11.26.1 CellFree Sciences Company Detail
11.26.2 CellFree Sciences Business Overview
11.26.3 CellFree Sciences Malaria Vaccines Introduction
11.26.4 CellFree Sciences Revenue in Malaria Vaccines Business (2018-2023)
11.26.5 CellFree Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Malaria Vaccines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Pre-Erythrocytic Vaccine
Table 3. Key Players of Erythrocytic Vaccine
Table 4. Key Players of Multi-antigen Vaccine
Table 5. Global Malaria Vaccines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Malaria Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Malaria Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Malaria Vaccines Market Share by Region (2018-2023)
Table 9. Global Malaria Vaccines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Malaria Vaccines Market Share by Region (2024-2029)
Table 11. Malaria Vaccines Market Trends
Table 12. Malaria Vaccines Market Drivers
Table 13. Malaria Vaccines Market Challenges
Table 14. Malaria Vaccines Market Restraints
Table 15. Global Malaria Vaccines Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Malaria Vaccines Market Share by Players (2018-2023)
Table 17. Global Top Malaria Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Vaccines as of 2022)
Table 18. Ranking of Global Top Malaria Vaccines Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Malaria Vaccines Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Malaria Vaccines Product Solution and Service
Table 22. Date of Enter into Malaria Vaccines Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Malaria Vaccines Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Malaria Vaccines Revenue Market Share by Type (2018-2023)
Table 26. Global Malaria Vaccines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Malaria Vaccines Revenue Market Share by Type (2024-2029)
Table 28. Global Malaria Vaccines Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Malaria Vaccines Revenue Market Share by Application (2018-2023)
Table 30. Global Malaria Vaccines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Malaria Vaccines Revenue Market Share by Application (2024-2029)
Table 32. North America Malaria Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Malaria Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Malaria Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Malaria Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Malaria Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Malaria Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Malaria Vaccines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Malaria Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Malaria Vaccines Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Malaria Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Malaria Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Malaria Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Malaria Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Malaria Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Malaria Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 47. GlaxoSmithKline Plc Company Detail
Table 48. GlaxoSmithKline Plc Business Overview
Table 49. GlaxoSmithKline Plc Malaria Vaccines Product
Table 50. GlaxoSmithKline Plc Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 51. GlaxoSmithKline Plc Recent Development
Table 52. Sanaria Inc Company Detail
Table 53. Sanaria Inc Business Overview
Table 54. Sanaria Inc Malaria Vaccines Product
Table 55. Sanaria Inc Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 56. Sanaria Inc Recent Development
Table 57. Nobelpharma Co Company Detail
Table 58. Nobelpharma Co Business Overview
Table 59. Nobelpharma Co Malaria Vaccines Product
Table 60. Nobelpharma Co Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 61. Nobelpharma Co Recent Development
Table 62. Sumaya Biotech Company Detail
Table 63. Sumaya Biotech Business Overview
Table 64. Sumaya Biotech Malaria Vaccines Product
Table 65. Sumaya Biotech Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 66. Sumaya Biotech Recent Development
Table 67. GenVec Company Detail
Table 68. GenVec Business Overview
Table 69. GenVec Malaria Vaccines Product
Table 70. GenVec Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 71. GenVec Recent Development
Table 72. Actiza Pharmaceutical Private Limited Company Detail
Table 73. Actiza Pharmaceutical Private Limited Business Overview
Table 74. Actiza Pharmaceutical Private Limited Malaria Vaccines Product
Table 75. Actiza Pharmaceutical Private Limited Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 76. Actiza Pharmaceutical Private Limited Recent Development
Table 77. AdvaCare Pharma Company Detail
Table 78. AdvaCare Pharma Business Overview
Table 79. AdvaCare Pharma Malaria Vaccines Product
Table 80. AdvaCare Pharma Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 81. AdvaCare Pharma Recent Development
Table 82. Ipca Laboratories Ltd Company Detail
Table 83. Ipca Laboratories Ltd Business Overview
Table 84. Ipca Laboratories Ltd Malaria Vaccines Product
Table 85. Ipca Laboratories Ltd Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 86. Ipca Laboratories Ltd Recent Development
Table 87. Bliss GVS Pharma Ltd Company Detail
Table 88. Bliss GVS Pharma Ltd Business Overview
Table 89. Bliss GVS Pharma Ltd Malaria Vaccines Product
Table 90. Bliss GVS Pharma Ltd Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 91. Bliss GVS Pharma Ltd Recent Development
Table 92. GeoVax Company Detail
Table 93. GeoVax Business Overview
Table 94. GeoVax Malaria Vaccines Product
Table 95. GeoVax Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 96. GeoVax Recent Development
Table 97. Pfizer Inc Company Detail
Table 98. Pfizer Inc Business Overview
Table 99. Pfizer Inc Malaria Vaccines Product
Table 100. Pfizer Inc Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 101. Pfizer Inc Recent Development
Table 102. VLP Therapeutics Company Detail
Table 103. VLP Therapeutics Business Overview
Table 104. VLP Therapeutics Malaria Vaccines Product
Table 105. VLP Therapeutics Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 106. VLP Therapeutics Recent Development
Table 107. OSIVAX Company Detail
Table 108. OSIVAX Business Overview
Table 109. OSIVAX Malaria Vaccines Product
Table 110. OSIVAX Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 111. OSIVAX Recent Development
Table 112. AJANTA PHARMA Company Detail
Table 113. AJANTA PHARMA Business Overview
Table 114. AJANTA PHARMA Malaria Vaccines Product
Table 115. AJANTA PHARMA Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 116. AJANTA PHARMA Recent Development
Table 117. Strides Pharma Science Limited Company Detail
Table 118. Strides Pharma Science Limited Business Overview
Table 119. Strides Pharma Science Limited Malaria Vaccines Product
Table 120. Strides Pharma Science Limited Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 121. Strides Pharma Science Limited Recent Development
Table 122. Mylan N.V. Company Detail
Table 123. Mylan N.V. Business Overview
Table 124. Mylan N.V. Malaria Vaccines Product
Table 125. Mylan N.V. Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 126. Mylan N.V. Recent Development
Table 127. Zydus Cadila Company Detail
Table 128. Zydus Cadila Business Overview
Table 129. Zydus Cadila Malaria Vaccines Product
Table 130. Zydus Cadila Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 131. Zydus Cadila Recent Development
Table 132. Cipla Inc Company Detail
Table 133. Cipla Inc Business Overview
Table 134. Cipla Inc Malaria Vaccines Product
Table 135. Cipla Inc Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 136. Cipla Inc Recent Development
Table 137. Sun Pharmaceutical Industries Ltd Company Detail
Table 138. Sun Pharmaceutical Industries Ltd Business Overview
Table 139. Sun Pharmaceutical Industries Ltd Malaria Vaccines Product
Table 140. Sun Pharmaceutical Industries Ltd Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 141. Sun Pharmaceutical Industries Ltd Recent Development
Table 142. Sanofi Company Detail
Table 143. Sanofi Business Overview
Table 144. Sanofi Malaria Vaccines Product
Table 145. Sanofi Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 146. Sanofi Recent Development
Table 147. Hikma Pharmaceuticals PLC Company Detail
Table 148. Hikma Pharmaceuticals PLC Business Overview
Table 149. Hikma Pharmaceuticals PLC Malaria Vaccines Product
Table 150. Hikma Pharmaceuticals PLC Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 151. Hikma Pharmaceuticals PLC Recent Development
Table 152. Amneal Pharmaceuticals LLC Company Detail
Table 153. Amneal Pharmaceuticals LLC Business Overview
Table 154. Amneal Pharmaceuticals LLC Malaria Vaccines Product
Table 155. Amneal Pharmaceuticals LLC Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 156. Amneal Pharmaceuticals LLC Recent Development
Table 157. Taj Pharmaceuticals Limited Company Detail
Table 158. Taj Pharmaceuticals Limited Business Overview
Table 159. Taj Pharmaceuticals Limited Malaria Vaccines Product
Table 160. Taj Pharmaceuticals Limited Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 161. Taj Pharmaceuticals Limited Recent Development
Table 162. Lupin Company Detail
Table 163. Lupin Business Overview
Table 164. Lupin Malaria Vaccines Product
Table 165. Lupin Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 166. Lupin Recent Development
Table 167. Novartis AG Company Detail
Table 168. Novartis AG Business Overview
Table 169. Novartis AG Malaria Vaccines Product
Table 170. Novartis AG Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 171. Novartis AG Recent Development
Table 172. CellFree Sciences Company Detail
Table 173. CellFree Sciences Business Overview
Table 174. CellFree Sciences Malaria Vaccines Product
Table 175. CellFree Sciences Revenue in Malaria Vaccines Business (2018-2023) & (US$ Million)
Table 176. CellFree Sciences Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Malaria Vaccines Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Malaria Vaccines Market Share by Type: 2022 VS 2029
Figure 3. Pre-Erythrocytic Vaccine Features
Figure 4. Erythrocytic Vaccine Features
Figure 5. Multi-antigen Vaccine Features
Figure 6. Global Malaria Vaccines Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Malaria Vaccines Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Community Centers Case Studies
Figure 11. Malaria Vaccines Report Years Considered
Figure 12. Global Malaria Vaccines Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Malaria Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Malaria Vaccines Market Share by Region: 2022 VS 2029
Figure 15. Global Malaria Vaccines Market Share by Players in 2022
Figure 16. Global Top Malaria Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Vaccines as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Malaria Vaccines Revenue in 2022
Figure 18. North America Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Malaria Vaccines Market Share by Country (2018-2029)
Figure 20. United States Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Malaria Vaccines Market Share by Country (2018-2029)
Figure 24. Germany Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Malaria Vaccines Market Share by Region (2018-2029)
Figure 32. China Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Malaria Vaccines Market Share by Country (2018-2029)
Figure 40. Mexico Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Malaria Vaccines Market Share by Country (2018-2029)
Figure 44. Turkey Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Malaria Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. GlaxoSmithKline Plc Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 47. Sanaria Inc Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 48. Nobelpharma Co Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 49. Sumaya Biotech Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 50. GenVec Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 51. Actiza Pharmaceutical Private Limited Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 52. AdvaCare Pharma Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 53. Ipca Laboratories Ltd Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 54. Bliss GVS Pharma Ltd Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 55. GeoVax Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 56. Pfizer Inc Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 57. VLP Therapeutics Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 58. OSIVAX Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 59. AJANTA PHARMA Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 60. Strides Pharma Science Limited Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 61. Mylan N.V. Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 62. Zydus Cadila Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 63. Cipla Inc Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 64. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 65. Sanofi Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 66. Hikma Pharmaceuticals PLC Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 67. Amneal Pharmaceuticals LLC Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 68. Taj Pharmaceuticals Limited Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 69. Lupin Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 70. Novartis AG Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 71. CellFree Sciences Revenue Growth Rate in Malaria Vaccines Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs